Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: PHARMACEUTICAL CARE: Patients who meets inclusion criteria will be allocated to standard care (control group) and pharmaceutical care (intervention group). Intervention group receives p
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Out Patients of both gender above the age of 65 diagnosed to have Type 2 DM using oral antidiabetic medications or insulin
Exclusion criteria
Exclusion criteria: Patients having other diseases such as heart diseases, cancer, renal failure, hepatic failure and human immune deficiency virus positive patients. Patients who are on therapy with steroids, immunosuppressants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in HBA1C level 0.5 to 1%, & reduction in total healthcare costs. Increase in medication adherence & disease knowledge. Delay in the occurrence of complications, decrease in adverse effects & improvement in quality of life.Timepoint: Data collection should be done at baseline & at intervals of 30 days, 60 days & 6 months. Final data collection will be done at 9 th month of first visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Delay in the occurrence of complications, decrease in adverse effects & improvement in quality of life.Timepoint: outcome assessed at 1 month, 3rd month 6th month & 9th month after baseline or first visit | — |
Countries
India
Contacts
Public ContactMANJU C S
GOVT MEDICAL COLLEGE KOZHIKODE
Outcome results
None listed